Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

XDx

Lucid Group strengthens its scientific leadership and client service team with two new hires

Two Lucid Group companies, Vivid and Leading Edge, welcome new talent to their teams.Eve Raebel joins Vivid as a medical writer. Eva has 2 years’ experience as a scientific writer...

Lucid Group Communications Limited

- PMLiVE

Novartis builds case for SMA gene therapy as FDA verdict looms

One shot therapy provided rapid improvement in motor function

- PMLiVE

Bluedog expands into the US with the appointment of George Pearson as Client Solutions Director

Bluedog, a Lucid Group Company, has elevated and expanded its creative team into the US with the appointment of George Pearson as Client Solutions Director.George is a highly experienced medical...

Lucid Group Communications Limited

Vivid welcomes magical new talent to the team

Vivid Medical Communications, a Lucid Group company, is delighted to announce two magical additions to the team.Deborah Blain joins Vivid as an Account Manager. With over 10 years’ experience in...

Lucid Group Communications Limited

- PMLiVE

Alcon spun off, leaner Novartis raises profit forecast

Expects three new launches in 2019

- PMLiVE

Poseida gets Novartis backing for myleoma CAR-T challenger

San Diego firm joins crowded field

Lucid Group announces the appointment of new CFO

Lucid Group continues to build its infrastructure in line with its ambitious growth plans by appointing Michael Joyce as Chief Financial Officer (CFO).Michael has considerable experience as a CFO and...

Lucid Group Communications Limited

- PMLiVE

Novartis makes case for gene therapy Zolgensma in SMA

New data revealed ahead of FDA review

- PMLiVE

Novartis and Amgen come to blows over migraine partnership

Amgen seeks to terminate contract

Novartis day

Novartis claims first place for psoriasis drug Cosentyx in China

Trial data from China helped support filing

- PMLiVE

UK biotech Artios Pharma appoints new medical director

Joins from senior role at Lilly

- PMLiVE

Novartis bolsters anti-inflammatory R&D with $1.6bn IFM Tre buy

Acquires its portfolio of NLRP3 targeting drugs

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links